Roche Pharma | The Tamiflu Fraud

In 1999, the FDA approved Tamiflu for the treatment & prevention of Influenza. In 2020, a Federal Judge denied Roche's motion to dismiss a $1.5 Billion Fraud suit. But, Roche is at it again!

Brief Background

On October 27th, 1999 the FDA approved Roche’s new antiviral drug Tamiflu (Oseltamivir) for the ‘treatment and prevention’ of Influenza.

Based on unpublished trial results, Roche made the following claims:

• Tamiflu reduces hospital admissions by 61%

• Tamiflu reduces secondary complications by 67%

• Tamiflu reduces the need for antibiotics (preve…